sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Dermatology OTC Medications Market...

Europe Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution) 

BMIRE00025069 | Pages: 216 | Pharmaceuticals | Jun 2022 | Type: Regional | Status: Published

The Europe dermatology OTC medications market is expected to grow from US$ 4,068.29 million in 2021 to US$ 5,321.86 million by 2028; it is estimated to grow at a CAGR of 3.9% from 2021 to 2028.

As per European Union, the middle-class population is expected to reach 5.3 billion by 2030, and the population of middle-class people is likely to be at the forefront. With significant changes in consumer behavior and consumption patterns, the middle-class expansion will likely drive regional economic development. With the increase in disposable incomes and better after-care treatment, the general attitude toward skin-related conditions is leading to the mounting adoption of dermatology OTC medications to treat skin conditions. Thus, a surge in the adoption rate of OTC medications, with the increase in disposable income of populations, support the growth of the dermatology OTC medications market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe dermatology OTC medications market. The Europe dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

Europe Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Europe Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Get more information on this report :


Europe Dermatology OTC Medications Market Segmentation    

 

The Europe dermatology OTC medications market is segmented into product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however the oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020, and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is also segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020; however online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and the rest of Europe.        

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the Europe dermatology OTC medications market.  

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Dermatology OTC Medications Market – By Product Type

1.3.2        Europe Dermatology OTC Medications Market – By Route of Administration

1.3.3        Europe Dermatology OTC Medications Market – By Indication

1.3.4        Europe Dermatology OTC Medications Market – By Distribution Channel

1.3.5        Europe Dermatology OTC Medications Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Dermatology OTC Medications Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Dermatology OTC Medications Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Growing Prevalence of Skin Problems

5.1.2        Increasing Income of Middle-class Population

5.2         Market Restraints

5.2.1        Inappropriate Use of OTC Medications

5.3         Market Opportunities

5.3.1        Escalating OTC Market across Several Economies

5.4         Future Trends

5.4.1        Surging Transition from Rx to OTC

5.5         Impact Analysis of Drivers and Restraints

6.           Dermatology OTC Medications Market– Europe Analysis

6.1         Europe Dermatology OTC Medications Market Revenue Forecast and Analysis

7.           Europe Dermatology OTC Medications Market Analysis – By Product Type

7.1         Overview

7.2         Europe Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3         Tablets and Capsules

7.3.1        Overview

7.3.2        Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4         Gels

7.4.1        Overview

7.4.2        Gels Market Revenue and Forecast to 2028 (US$ million)

7.5         Creams and Ointments

7.5.1        Overview

7.5.2        Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6         Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ million)

8.           Europe Dermatology OTC medications Market Analysis – By Route of Administration

8.1         Overview

8.2         Europe Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3         Topical

8.3.1        Overview

8.3.2        Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Dermatology OTC Medications Market Analysis – By Indication

9.1         Overview

9.2         Europe Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3         Dermatitis

9.3.1        Overview

9.3.2        Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3        Atopic Dermatitis

9.3.3.1          Overview

9.3.3.2          Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4        Contact Dermatitis

9.3.4.1          Overview

9.3.4.2          Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5        Others

9.3.5.1          Overview

9.3.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Acne

9.4.1        Overview

9.4.2        Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3        Non-Inflammatory Acne

9.4.3.1          Overview

9.4.3.2          Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4        Inflammatory Acne

9.4.4.1          Overview

9.4.4.2          Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5         Psoriasis

9.5.1        Overview

9.5.2        Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3        Plaque Psoriasis

9.5.3.1          Overview

9.5.3.2          Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4        Guttate Psoriasis

9.5.4.1          Overview

9.5.4.2          Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5        Others

9.5.5.1          Overview

9.5.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6         Skin Bleaching

9.6.1        Overview

9.6.2        Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7         Fungal Disease

9.7.1        Overview

9.7.2        Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3        Athlete's Foot

9.7.3.1          Overview

9.7.3.2          Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4        Ringworm

9.7.4.1          Overview

9.7.4.2          Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5        Fungal Nail Infections

9.7.5.1          Overview

9.7.5.2          Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6        Others

9.7.6.1          Overview

9.7.6.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8         Warts

9.8.1        Overview

9.8.2        Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3        Common Warts

9.8.3.1          Overview

9.8.3.2          Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4        Flat Warts

9.8.4.1          Overview

9.8.4.2          Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5        Others

9.8.5.1          Overview

9.8.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.        Europe Dermatology OTC medications Market Analysis – By Distribution Channel

10.1      Overview

10.2      Europe Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Offline Distribution

10.4.1     Overview

10.4.2     Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3     Retail and Hospital Pharmacies

10.4.3.1       Overview

10.4.3.2       Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4     Super and Hyper Markets

10.4.4.1       Overview

10.4.4.2       Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11.        Europe Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Europe Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.1.1     Overview

11.1.3     Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.4     Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1       Overview

11.1.4.2       Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.3       Germany: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4.4       Germany: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.4.5       Germany: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.4.5.1       Germany: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.4.5.2       Germany: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.4.5.3       Germany: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.4.5.4       Germany: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.4.5.5       Germany: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.4.6       Germany: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.4.6.1       Germany: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.5     France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1       Overview

11.1.5.2       France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.3       France: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.5.4       France: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.5.5       France: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.5.5.1       France: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.5.5.2       France: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.5.5.3       France: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.5.5.4       France: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.5.5.5       France: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.5.6       France: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.5.6.1       France: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.6     UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1       Overview

11.1.6.2       UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.3       UK: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.6.4       UK: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.6.5       UK: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.6.5.1       UK: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.6.5.2       UK: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.6.5.3       UK: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.6.5.4       UK: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.6.5.5       UK: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.6.6       UK: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.6.6.1       UK: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.7     Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1       Overview

11.1.7.2       Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3       Italy: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.7.4       Italy: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.7.5       Italy: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.7.5.1       Italy: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.7.5.2       Italy: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.7.5.3       Italy: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.7.5.4       Italy: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.7.5.5       Italy: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.7.6       Italy: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.7.6.1       Italy: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.8     Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1       Overview

11.1.8.2       Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.3       Spain: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.8.4       Spain: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.5       Spain: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.8.5.1       Spain: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.8.5.2       Spain: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.8.5.3       Spain: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.8.5.4       Spain: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.8.5.5       Spain: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.8.6       Spain: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8.6.1       Spain: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.9     Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1       Overview

11.1.9.2       Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.3       Rest of Europe: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.9.4       Rest of Europe: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.9.5       Rest of Europe: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.9.5.1       Rest of Europe: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.9.5.2       Rest of Europe: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.9.5.3       Rest of Europe: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.9.5.4       Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.9.5.5       Rest of Europe: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.9.6       Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.9.6.1       Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Germany: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 6.             Germany: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 7.             Germany: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 8.             Germany: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 9.             Germany: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Germany: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 12.          France: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          France: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          France: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          France: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 16.          France: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 17.          France: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 18.          France: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 19.          France: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 20.          France: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.          France: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 22.          UK: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          UK: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          UK: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          UK: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 26.          UK: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 27.          UK: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 28.          UK: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 29.          UK: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 30.          UK: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.          UK: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 32.          Italy: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 33.          Italy: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 34.          Italy: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 35.          Italy: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 36.          Italy: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 37.          Italy: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 38.          Italy: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 39.          Italy: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 40.          Italy: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 41.          Italy: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 42.          Spain: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 43.          Spain: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 44.          Spain: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 45.          Spain: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 46.          Spain: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 47.          Spain: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 48.          Spain: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 49.          Spain: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 50.          Spain: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 51.          Spain: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 52.          Rest of Europe: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 53.          Rest of Europe: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 54.          Rest of Europe: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 55.          Rest of Europe: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 56.          Rest of Europe: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 57.          Rest of Europe: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 58.          Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 59.          Rest of Europe: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 60.          Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 61.          Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 62.          Recent Inorganic Growth Strategies

Table 63.          Recent Organic Growth Strategies

Table 64.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Dermatology OTC Medications Market Segmentation

Figure 2.           Europe Dermatology OTC Medications Market, By Country

Figure 3.           Europe Dermatology OTC Medications Market Overview

Figure 4.           Creams and Ointments Segment Held the Largest Share of the Market in 2021

Figure 5.           Germany held the Largest Share of the Market in 2021

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Dermatology OTC Medications Market – By Forecast and Analysis

Figure 10.        Europe Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 11.        Europe Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 12.        Europe Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 13.        Europe Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 14.        Europe Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 15.        Europe Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 16.        Europe Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 19.        Europe Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Europe Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Europe Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Europe Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Europe Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Europe Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Europe Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Europe Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Europe Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Europe Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Europe Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Europe Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Europe Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 42.        Europe Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Europe Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Europe Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Europe Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Europe: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 48.        Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 53.        Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

  1. Bausch Health Companies Inc.
  2. Bayer AG
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S   
  8. Perrigo Company plc
  9. Viatris Inc.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe dermatology OTC medications market.       
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription